Since 2010, seven drugs have received FDA approval for the treatment of advanced prostate cancer.  Dr. Sartor has been directly involved at a national leadership level – as either principal investigator, co-principal investigator, or chair of the Data Monitoring committee – for five out of the seven.    These are the first new treatment options offering hope for men with advanced disease since 2004, and they were only possible through large, multi-institutional clinical research trials.